United Hearts, Same Path; Same Path, Same Journey. On January 15th, Xingguang Pharmaceutical in Zhuhai and Hongjitang Pharmaceutical Group held a signing ceremony in Jinan, focusing on cooperation in the field of detoxification and blood circulation for traditional Chinese medicine in the male health sector.
At 10:00 in the morning, the signing ceremony between Hongjitang Pharmaceutical and Xingguang Pharmaceutical in Zhuhai officially began. The ceremony was hosted by Zhang Chong, Vice Chairman of Hongjitang Pharmaceutical. Speeches were delivered by Liu Tao, Chairman of Hongjitang Pharmaceutical, and Zhou Juwei, Chairman and General Manager of Xingguang Pharmaceutical, representing both companies.
Hongjitang Pharmaceutical Group Chairman Liu Tao introduced the development of intelligent manufacturing at Hongjitang Pharmaceutical to the guests. Currently, Hongjitang Pharmaceutical has established a series of intelligent manufacturing projects in traditional Chinese medicine, featuring various highlights and leading-edge technologies. These projects play a crucial role in leading the transformation and upgrading of the traditional Chinese medicine industry, contributing significantly to the high-quality development of the industry. This also lays the foundation for a deeper collaboration with Xingguang Pharmaceutical in Zhuhai. Hongjitang Pharmaceutical is committed to living up to expectations, integrating expert resources, planning product strategies effectively, ensuring that high-quality products demonstrate clinical value, make a positive impact, and contribute to the well-being of the public.
In his speech, Zhou Juwei, Chairman and General Manager of Xingguang Pharmaceutical in Zhuhai, expressed his deep admiration for Hongjitang Pharmaceutical’s corporate culture and product quality during the visit. He highlighted the significance of the cooperation in the detoxification and blood circulation field, especially with the well-known Qianlie Xin Capsule. The combination of these two products has precise therapeutic effects, presenting broad market prospects. Xingguang Pharmaceutical is committed to working hand in hand with Hongjitang Pharmaceutical, aiming to expand and strengthen the products, creating a blockbuster product with a market size exceeding one billion, and benefiting a wide range of prostate patients.
Subsequently, Wu Suiwang, the Executive Deputy General Manager of Xingguang Pharmaceutical in Zhuhai, provided an introduction to the company’s general situation, overall business layout, and key products.
With the witness of leaders and guests in attendance, Zhou Juwei, Chairman and General Manager of Xingguang Pharmaceutical in Zhuhai, and Zhang Ran, President of Shandong Hongjitang Pharmaceutical Group Co., Ltd., went on stage to sign the cooperation agreement. This signifies a significant step forward and marks the entry into a new development stage for the deep collaboration between the two parties. In the future, both sides aim to achieve complementary advantages, share resources, cooperate for mutual benefit, and jointly seek development. Through practical actions, they are committed to implementing national strategies and working together to create a better future.